These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 33100271)

  • 1. Metoprolol Impairs
    Moore CL; Henry DS; McClenahan SJ; Ball KK; Rusch NJ; Rhee SW
    J Pharmacol Exp Ther; 2021 Jan; 376(1):127-135. PubMed ID: 33100271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta1-adrenergic receptor-mediated dilation of rat cerebral artery requires Shaker-type KV1 channels on PSD95 scaffold.
    Moore CL; McClenahan SJ; Hanvey HM; Jang DS; Nelson PL; Joseph BK; Rhee SW
    J Cereb Blood Flow Metab; 2015 Sep; 35(9):1537-46. PubMed ID: 25966954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Beta-1-Receptor Blocker Nebivolol Elicits Dilation of Cerebral Arteries by Reducing Smooth Muscle [Ca2+]i.
    Cseplo P; Vamos Z; Ivic I; Torok O; Toth A; Koller A
    PLoS One; 2016; 11(10):e0164010. PubMed ID: 27716772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metoprolol impairs resistance artery function in mice.
    El Beheiry MH; Heximer SP; Voigtlaender-Bolz J; Mazer CD; Connelly KA; Wilson DF; Beattie WS; Tsui AK; Zhang H; Golam K; Hu T; Liu E; Lidington D; Bolz SS; Hare GM
    J Appl Physiol (1985); 2011 Oct; 111(4):1125-33. PubMed ID: 21799135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PDE3, but not PDE4, reduces β₁ - and β₂-adrenoceptor-mediated inotropic and lusitropic effects in failing ventricle from metoprolol-treated patients.
    Molenaar P; Christ T; Hussain RI; Engel A; Berk E; Gillette KT; Chen L; Galindo-Tovar A; Krobert KA; Ravens U; Levy FO; Kaumann AJ
    Br J Pharmacol; 2013 Jun; 169(3):528-38. PubMed ID: 23489141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of β
    Mori A; Sekito A; Sakamoto K; Ishii K; Nakahara T
    Naunyn Schmiedebergs Arch Pharmacol; 2017 May; 390(5):527-533. PubMed ID: 28160015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic administration of β-blockers on airway responsiveness in a murine model of heart failure.
    Rinaldi B; Capuano A; Gritti G; Donniacuo M; Scotto Di Vettimo A; Sodano L; Rafaniello C; Rossi F; Matera MG
    Pulm Pharmacol Ther; 2014 Aug; 28(2):109-13. PubMed ID: 24769100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic treatment with the new ultra-long-acting β2 -adrenoceptor agonist indacaterol alone or in combination with the β1 -adrenoceptor blocker metoprolol on cardiac remodelling.
    Rinaldi B; Donniacuo M; Sodano L; Gritti G; Martuscelli E; Orlandi A; Rafaniello C; Rossi F; Calzetta L; Capuano A; Matera MG
    Br J Pharmacol; 2015 Jul; 172(14):3627-37. PubMed ID: 25825265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of combined clenbuterol and metoprolol therapy on reverse remodelling during mechanical unloading.
    Navaratnarajah M; Siedlecka U; Ibrahim M; van Doorn C; Soppa G; Gandhi A; Shah A; Kukadia P; Yacoub MH; Terracciano CM
    PLoS One; 2014; 9(9):e92909. PubMed ID: 25268495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of cardiac fibrosis by β-blocker in G protein-independent and G protein-coupled receptor kinase 5/β-arrestin2-dependent Signaling pathways.
    Nakaya M; Chikura S; Watari K; Mizuno N; Mochinaga K; Mangmool S; Koyanagi S; Ohdo S; Sato Y; Ide T; Nishida M; Kurose H
    J Biol Chem; 2012 Oct; 287(42):35669-35677. PubMed ID: 22888001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
    Metra M; Nodari S; D'Aloia A; Muneretto C; Robertson AD; Bristow MR; Dei Cas L
    J Am Coll Cardiol; 2002 Oct; 40(7):1248-58. PubMed ID: 12383572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of cardiac events caused by surgical stress in aged rats: simultaneously activating β2-adrenoceptor and inhibiting β1-adrenoceptor.
    Sun Y; Wang Y; Zhang L; Xu C; Liu Y; Kang S; Yan C; Li D; Sun H
    Stress; 2014 Jul; 17(4):373-81. PubMed ID: 24754893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normotensive sodium loading in normal man: regulation of renin secretion during beta-receptor blockade.
    Mølstrøm S; Larsen NH; Simonsen JA; Washington R; Bie P
    Am J Physiol Regul Integr Comp Physiol; 2009 Feb; 296(2):R436-45. PubMed ID: 19073901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nebivolol prevents desensitization of β-adrenoceptor signaling and induction of cardiac hypertrophy in response to isoprenaline beyond β1-adrenoceptor blockage.
    Ozakca I; Arioglu-Inan E; Esfahani H; Altan VM; Balligand JL; Kayki-Mutlu G; Ozcelikay AT
    Am J Physiol Heart Circ Physiol; 2013 May; 304(9):H1267-76. PubMed ID: 23457011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of chronic pharmacological manipulation of beta-adrenoreceptor subtype signaling in rodent dilated ischemic cardiomyopathy.
    Ahmet I; Krawczyk M; Heller P; Moon C; Lakatta EG; Talan MI
    Circulation; 2004 Aug; 110(9):1083-90. PubMed ID: 15313944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norepinephrine elicits beta2-receptor-mediated dilation of isolated human coronary arterioles.
    Sun D; Huang A; Mital S; Kichuk MR; Marboe CC; Addonizio LJ; Michler RE; Koller A; Hintze TH; Kaley G
    Circulation; 2002 Jul; 106(5):550-5. PubMed ID: 12147535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotective and survival benefits of long-term combined therapy with beta2 adrenoreceptor (AR) agonist and beta1 AR blocker in dilated cardiomyopathy postmyocardial infarction.
    Ahmet I; Krawczyk M; Zhu W; Woo AY; Morrell C; Poosala S; Xiao RP; Lakatta EG; Talan MI
    J Pharmacol Exp Ther; 2008 May; 325(2):491-9. PubMed ID: 18287209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The IgG3 subclass of β1-adrenergic receptor autoantibodies is an endogenous biaser of β1AR signaling.
    Mohan ML; Nagatomo Y; Saha PP; Mukherjee SD; Engelman T; Morales R; Hazen SL; Tang WHW; Naga Prasad SV
    Mol Biol Cell; 2021 Apr; 32(7):622-633. PubMed ID: 33534612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic β-adrenoceptor antagonist treatment controls cardiovascular remodeling in heart failure in the aging spontaneously hypertensive rat.
    Chan V; Fenning A; Hoey A; Brown L
    J Cardiovasc Pharmacol; 2011 Oct; 58(4):424-31. PubMed ID: 21709583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic β1-adrenergic blockade enhances myocardial β3-adrenergic coupling with nitric oxide-cGMP signaling in a canine model of chronic volume overload: new insight into mechanisms of cardiac benefit with selective β1-blocker therapy.
    Trappanese DM; Liu Y; McCormick RC; Cannavo A; Nanayakkara G; Baskharoun MM; Jarrett H; Woitek FJ; Tillson DM; Dillon AR; Recchia FA; Balligand JL; Houser SR; Koch WJ; Dell'Italia LJ; Tsai EJ
    Basic Res Cardiol; 2015 Jan; 110(1):456. PubMed ID: 25480109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.